CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Phelan, S. A.
Right arrow Articles by Call, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Phelan, S. A.
Right arrow Articles by Call, K. M.

Cell Growth & Differentiation, Vol 5, Issue 6 677-686, Copyright © 1994 by American Association of Cancer Research


ARTICLES

Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells

SA Phelan, C Lindberg and KM Call
Department of Molecular and Cellular Toxicology, Harvard School of Public Health, Boston, Massachusetts 02115.

Evidence implicates the product of the Wilms' tumor suppressor gene, WT1, in proliferation and differentiation of target tissues during development. Study of the regulation of other tumor suppressor genes during these processes has been instrumental in defining their interactions and functions. In this study, we performed experiments to assess the suitability of the human K562 erythroleukemia cell line for studying the WT1 gene during differentiation. We predicted that WT1 mRNA would be decreased during induction of differentiation of K562 cells based on observations of decreased WT1 mRNA during kidney development and in differentiated Wilms' tumors and leukemias. Accordingly, we found that WT1 mRNA was down-regulated in K562 cells during induction of erythroid and megakaryocytic differentiation by sodium butyrate and 12-O-tetradecanoylphorbol-13-acetate, respectively. Down-regulation of WT1 mRNA was not a generalized phenomenon of growth inhibition. WT1 mRNA was not down-regulated when 12-O-tetradecanoylphorbol-13-acetate-induced differentiation was blocked by bryostatin-1. During 12-O-tetradecanoylphorbol-13-acetate treatment, the decrease in WT1 mRNA was rapid (within 5 min), continuous, and occurred, at least in part, posttranscriptionally. An analysis of the 5' flanking region and transcription initiation sites of the human WT1 gene also was performed. Our data suggest that K562 cells will be a valuable system for unraveling signal transduction pathways by which WT1 is regulated and for investigating the interactions and role of WT1 in differentiation.


This article has been cited by other articles:


Home page
J Biol ChemHome page
K. M. Kirschner, N. Wagner, K.-D. Wagner, S. Wellmann, and H. Scholz
The Wilms Tumor Suppressor Wt1 Promotes Cell Adhesion through Transcriptional Activation of the {alpha}4integrin Gene
J. Biol. Chem., October 20, 2006; 281(42): 31930 - 31939.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Renshaw, R. M. Orr, M. I. Walton, R. te Poele, R. D. Williams, E. V. Wancewicz, B. P. Monia, P. Workman, and K. Pritchard-Jones
Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: Antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival
Mol. Cancer Ther., November 1, 2004; 3(11): 1467 - 1484.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. A. Alberta, G. M. Springett, H. Rayburn, T. A. Natoli, J. Loring, J. A. Kreidberg, and D. Housman
Role of the WT1 tumor suppressor in murine hematopoiesis
Blood, April 1, 2003; 101(7): 2570 - 2574.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
N. Wagner, K.-D. Wagner, G. Schley, S. E. Coupland, H. Heimann, R. Grantyn, and H. Scholz
The Wilms' Tumor Suppressor Wt1 Is Associated with the Differentiation of Retinoblastoma Cells
Cell Growth Differ., July 1, 2002; 13(7): 297 - 305.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
S. I. Smith, M. Down, A. W. Boyd, and C. L. Li
Expression of the Wilms' Tumor Suppressor Gene, WT1, Reduces the Tumorigenicity of the Leukemic Cell Line M1 in C.B-17 scid/scid Mice
Cancer Res., February 1, 2000; 60(4): 808 - 814.
[Abstract] [Full Text]


Home page
J Biol ChemHome page
V. Scharnhorst, P. Dekker, A. J. van der Eb, and A. G. Jochemsen
Internal Translation Initiation Generates Novel WT1 Protein Isoforms with Distinct Biological Properties
J. Biol. Chem., August 13, 1999; 274(33): 23456 - 23462.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
M. W. Mayo, C.-Y. Wang, S. S. Drouin, L. V. Madrid, A. F. Marshall, J. C. Reed, B. E. Weissman, and A. S. Baldwin
WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene
EMBO J., July 15, 1999; 18(14): 3990 - 4003.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
C. McCoy, S. B. McGee, and M. M. Cornwell
The Wilms' Tumor Suppressor, WT1, Inhibits 12-O-Tetradecanoylphorbol-13-acetate Activation of the Multidrug Resistance-1 Promoter
Cell Growth Differ., June 1, 1999; 10(6): 377 - 386.
[Abstract] [Full Text]


Home page
BloodHome page
S. I. Smith, D. Weil, G. R. Johnson, A. W. Boyd, and C. L. Li
Expression of the Wilms' Tumor Suppressor Gene, WT1, Is Upregulated by Leukemia Inhibitory Factor and Induces Monocytic Differentiation in M1 Leukemic Cells
Blood, February 1, 1998; 91(3): 764 - 773.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
G. C. Fraizer, R. Shimamura, X. Zhang, and G. F. Saunders
PAX 8 Regulates Human WT1 Transcription through a Novel DNA Binding Site
J. Biol. Chem., December 5, 1997; 272(49): 30678 - 30687.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Bergmann, C. Miething, U. Maurer, J. Brieger, T. Karakas, E. Weidmann, and D. Hoelzer
High Levels of Wilms' Tumor Gene (wt1) mRNA in Acute Myeloid Leukemias Are Associated With a Worse Long-Term Outcome
Blood, August 1, 1997; 90(3): 1217 - 1225.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. G. Tenen, R. Hromas, J. D. Licht, and D.-E. Zhang
Transcription Factors, Normal Myeloid Development, and Leukemia
Blood, July 15, 1997; 90(2): 489 - 519.
[Full Text] [PDF]


Home page
BloodHome page
K. Inoue, H. Ogawa, Y. Sonoda, T. Kimura, H. Sakabe, Y. Oka, S. Miyake, H. Tamaki, Y. Oji, T. Yamagami, et al.
Aberrant Overexpression of the Wilms Tumor Gene (WT1) in Human Leukemia
Blood, February 15, 1997; 89(4): 1405 - 1412.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. M. Hewitt, G. C. Fraizer, Y.-J. Wu, F. J. Rauscher III, and G. F. Saunders
Differential Function of Wilms Tumor Gene WT1 Splice Isoforms in Transcriptional Regulation
J. Biol. Chem., April 12, 1996; 271(15): 8588 - 8592.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1994 by the American Association of Cancer Research.